SCHEMBL3825344

SCHEMBL3825344

COc1cccc(-c2cc3cc(OC)c(OC)cc3cn2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.61
RAB9A P51151 5/20 0.61
PDGFRB P09619 1/20 0.59
PDGFRA P16234 1/20 0.59
CASP3 P42574 2/20 0.56
SENP7 Q9BQF6 2/20 0.56
CLK4 Q9HAZ1 3/20 0.53
DYRK1A Q13627 1/20 0.53
CYP19A1 P11511 1/20 0.50
FYN P06241 1/20 0.48
TOP1 P11387 1/20 0.48
KDM1A O60341 1/20 0.48
LMNA P02545 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
TSHR P16473 2/20 0.47
CYP2C19 P33261 2/20 0.47
ALDH1A1 P00352 2/20 0.47
GLA P06280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3825612 0.86 RAB9A (0.71) NPC1RAB9APDGFRBPDGFRACASP3
SCHEMBL3830100 0.84 NPC1 (0.71) NPC1RAB9APDGFRBPDGFRACASP3
SCHEMBL3318438 0.84 NPC1 (0.69) NPC1RAB9APDGFRBPDGFRACASP3
SCHEMBL3826270 0.84 NPC1 (0.64) NPC1RAB9ACASP3SENP7CLK4
Hydrochloric Acid SCHEMBL3318446 0.83 NPC1 (0.67) NPC1RAB9APDGFRBPDGFRACASP3
SCHEMBL2458692 0.83 NPC1 (0.76) NPC1RAB9APDGFRBPDGFRACASP3
SCHEMBL2457696 0.81 PDGFRB (0.55) NPC1RAB9APDGFRBPDGFRACASP3
SCHEMBL13458067 0.80 DYRK1A (0.61) NPC1RAB9APDGFRBPDGFRACLK4
SCHEMBL3825604 0.78 NPC1 (0.68) NPC1RAB9ACASP3SENP7ALDH1A1
SCHEMBL13870935 0.77 PDGFRB (0.61) NPC1RAB9APDGFRBPDGFRACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099765-A2 5, 6, OR 7-SUBSTITUTED-3-(HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS Rexahn Pharmaceuticals, Inc. (US) 2009-09-16 EP disclosed
WO-2008063548-A2 5, 6, OR 7-SUBSTITUTED-S- (HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS REXAHN PHARMACEUTICALS, INC. (US) 2008-05-29 WO disclosed